Cite Filings / STLN / 0001193125-21-336832
Feed Companies Filings Check
Sign in
SC 13D

Beneficial Ownership Report

Starling Oncology, Inc. · Filed 2021-11-22 · Acc 0001193125-21-336832

Documents 1

  • SC 13D Beneficial Ownership Report , d254266dsc13d.htm

Around this filing

  • 2021-11-22 SC 13D Beneficial Ownership Report
  • 2021-11-22 3 Initial Statement of Ownership
  • 2021-11-22 SC 13D Beneficial Ownership Report
  • 2021-11-22 8-K/A Material agreement · Acquisition or sale completed
  • 2021-11-22 SC 13D Beneficial Ownership Report
  • 2021-11-22 4/A Director acquired 4,109,771 shares (grant or award)
  • 2021-11-22 3 Initial Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-13 SCHEDULE 13G/A · Chernett Jorey 5.6%
  2. 2026-05-15 SCHEDULE 13D/A · M33 Growth I L.P. 4.94%
  3. 2026-03-16 SCHEDULE 13G/A · Chernett Jorey 10.2%
  4. 2026-01-15 SCHEDULE 13G · Chernett Jorey 5.2%
  5. 2025-11-20 SCHEDULE 13D/A · M33 Growth I LP 5.46%
  6. 2025-09-05 SCHEDULE 13D/A · M33 Growth I LP 9.79%
  7. 2025-06-24 SCHEDULE 13G/A · FOG Ventures Investments, LLC 0%
  8. 2025-04-23 SCHEDULE 13D/A · Ravi Sarin 4.7%
  9. 2025-03-28 SCHEDULE 13D/A · M33 Growth I LP 19.99%
  10. 2024-12-06 SCHEDULE 13G/A · FMR LLC 0.0%
Loading d254266dsc13d.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…